4//SEC Filing
Peck Ronald 4
Accession 0001209191-22-001202
CIK 0001655759other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:00 PM ET
Size
15.9 KB
Accession
0001209191-22-001202
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Peck Ronald
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-12-30$80.96/sh−8,629$698,604→ 5,402 total - Exercise/Conversion
Stock Option (right to buy)
2021-12-30−5,625→ 46,559 totalExercise: $26.58Exp: 2029-07-28→ Common Stock (5,625 underlying) - Exercise/Conversion
Common Stock
2021-12-30$47.38/sh+14,375$681,088→ 19,777 total - Exercise/Conversion
Common Stock
2021-12-30$26.58/sh+5,625$149,513→ 25,402 total - Sale
Common Stock
2021-12-30$80.35/sh−11,371$913,660→ 14,031 total - Exercise/Conversion
Stock Option (right to buy)
2021-12-30−14,375→ 40,625 totalExercise: $47.38Exp: 2030-02-26→ Common Stock (14,375 underlying)
Footnotes (6)
- [F1]The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.76 to $80.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.76 to $81.515, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range set forth in this footnote.
- [F5]This option award was granted on February 27, 2020. 1/4 of the shares underlying the award vested on February 27, 2021, with the remainder of the shares vesting in equal monthly installments following February 27, 2021 through February 27, 2024.
- [F6]This option award was granted on July 29, 2019. 1/4 of the shares underlying the award vested on July 29, 2020, with the remainder of the shares vesting in equal monthly installments following July 29, 2020 through July 29, 2023.
Documents
Issuer
ARVINAS, INC.
CIK 0001655759
Entity typeother
Related Parties
1- filerCIK 0001783868
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:00 PM ET
- Size
- 15.9 KB